SOUTH PLAINFIELD, N.J.,
April 11, 2024 /PRNewswire/ -- PTC
Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company
will host a webcast conference call to report its first quarter
2024 financial results and provide an update on the company's
business and outlook on Thursday, April
25, at 4:30 p.m.
ET.
To access the call by phone, please click here to register
and you will be provided with dial-in details. To avoid delays, we
recommend participants dial in to the conference call 15 minutes
prior to the start of the call. The webcast conference call can be
accessed on the Investor section of the PTC website at
https://ir.ptcbio.com/events-presentations. A replay of the call
will be available approximately two hours after completion
of the call and will be archived on the company's website for
30 days.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery,
development and commercialization of clinically differentiated
medicines that provide benefits to patients with rare disorders.
PTC's ability to innovate to identify new therapies and to globally
commercialize products is the foundation that drives investment in
a robust and diversified pipeline of transformative medicines.
PTC's mission is to provide access to best-in-class treatments for
patients who have little to no treatment options. PTC's strategy is
to leverage its strong scientific and clinical expertise and global
commercial infrastructure to bring therapies to patients. PTC
believes this allows it to maximize value for all its stakeholders.
To learn more about PTC, please visit us at www.ptcbio.com and
follow us on Facebook, Instagram, LinkedIn and Twitter at
@PTCBio.
For More Information:
Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original
content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss--first-quarter-2024-financial-results-302113745.html
SOURCE PTC Therapeutics, Inc.